110 related articles for article (PubMed ID: 9610907)
1. The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice.
Bei R; Guptill V; Masuelli L; Kashmiri SV; Muraro R; Frati L; Schlom J; Kantor J
J Immunother; 1998 May; 21(3):159-69. PubMed ID: 9610907
[TBL] [Abstract][Full Text] [Related]
2. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo.
Hamm S; Heit A; Koffler M; Huster KM; Akira S; Busch DH; Wagner H; Bauer S
Int Immunol; 2007 Mar; 19(3):297-304. PubMed ID: 17289655
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
[TBL] [Abstract][Full Text] [Related]
6. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
[TBL] [Abstract][Full Text] [Related]
7. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
[TBL] [Abstract][Full Text] [Related]
8. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid.
Chen W; Yan W; Huang L
Cancer Immunol Immunother; 2008 Apr; 57(4):517-30. PubMed ID: 17724588
[TBL] [Abstract][Full Text] [Related]
9. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immune responses and anti-tumor activity by baculovirus recombinant carcinoembryonic antigen (CEA) in mice primed with the recombinant vaccinia CEA.
Bei R; Kantor J; Kashmiri SV; Abrams S; Schlom J
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):275-82. PubMed ID: 7881636
[TBL] [Abstract][Full Text] [Related]
11. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.
Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y
Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026
[TBL] [Abstract][Full Text] [Related]
12. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation.
Mehravaran A; Jaafari MR; Jalali SA; Khamesipour A; Tafaghodi M; Hojatizade M; Abbasi A; Badiee A
Iran J Immunol; 2015 Dec; 12(4):274-87. PubMed ID: 26714419
[TBL] [Abstract][Full Text] [Related]
13. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses.
Hodge JW; McLaughlin JP; Kantor JA; Schlom J
Vaccine; 1997; 15(6-7):759-68. PubMed ID: 9178479
[TBL] [Abstract][Full Text] [Related]
14. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
McLaughlin JP; Schlom J; Kantor JA; Greiner JW
Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant.
Ponnazhagan S; Mahendra G; Lima J; Aldrich WA; Jenkins CB; Ren C; Kumar S; Kallman L; Strong TV; Shaw DR; Triozzi PL
Hum Gene Ther; 2004 Sep; 15(9):856-64. PubMed ID: 15353040
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
[TBL] [Abstract][Full Text] [Related]
17. T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice.
Akkaya M; Akkaya B; Sheehan PW; Miozzo P; Pena M; Qi CF; Manzella-Lapeira J; Bolland S; Pierce SK
Eur J Immunol; 2017 Nov; 47(11):1890-1899. PubMed ID: 28762497
[TBL] [Abstract][Full Text] [Related]
18. Serological and biochemical characterization of recombinant baculovirus carcinoembryonic antigen.
Bei R; Kantor J; Kashmiri SV; Schlom J
Mol Immunol; 1994 Jul; 31(10):771-80. PubMed ID: 7518569
[TBL] [Abstract][Full Text] [Related]
19. PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.
Naseri H; Eskandari F; Jaafari MR; Khamesipour A; Abbasi A; Badiee A
Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28921566
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
